WILLIAM H. BAUGHMAN, Jr., Magistrate Judge.
Before me
Davis, who was 38 years old at the time of the administrative hearing,
The ALJ, whose decision became the final decision of the Commissioner, found that Davis had the following severe impairments: degenerative disc and joint disease of the lumbosacral spine; bronchitis; mood disorder (characterized as depression, bipolar disorder, adjustment disorder with depressed mood and dysthymic disorder); generalized anxiety disorder; and personality disorder with borderline and histrionic traits.
After concluding that the relevant impairments did not meet or equal a listing,
Based on an answer to a hypothetical question posed to the vocational expert at the hearing setting forth the residual functional capacity finding quoted above, the ALJ determined that a significant number of jobs existed locally and nationally that Davis could perform.
Davis asks for reversal of the Commissioner's decision on the ground that it does not have the support of substantial evidence in the administrative record. Specifically, Davis presents as a single issue for judicial review, whether the ALJ improperly weighed the opinion of the medical expert, Dr. Sai R. Nimmagadda.
For the reasons that follow, I will conclude that the ALJ's finding of no disability is not supported by substantial evidence and, therefore, must be reversed, and the matter remanded.
The Sixth Circuit in Buxton v. Halter reemphasized the standard of review applicable to decisions of the ALJs in disability cases:
Viewed in the context of a jury trial, all that is necessary to affirm is that reasonable minds could reach different conclusions on the evidence. If such is the case, the Commissioner survives "a directed verdict" and wins.
I will review the findings of the ALJ at issue here consistent with that deferential standard. The relevant evidence from the administrative record will be discussed in detail as part of the following analysis.
As noted, this case presents the sole question of whether the ALJ properly assigned little weight to the opinion of Dr. Sai Simmagadda, who testified in this matter as a medical expert.
The ALJ dealt with the opinion of the ME by first noting that he had engaged Dr. Nimmagadda "[i]n an attempt to clarify the record."
In the end, the ALJ concluded that he "cannot give much weight to [Dr. Simmigadda's] testimony because he was not firm in his answers and he provided little guidance with respect to whether [Davis] meets or equals a listed impairment."
Essentially, Davis contends that the ALJ's reasons for discounting Dr. Simmagadda's testimony are based on an incorrect summary of Dr. Simmagadda's testimony, and an improper characterization of Dr. Simmagadda's views as "hedging" about whether Davis's functional limitations were marked or moderate.
Specifically, she notes that Dr. Nimmagadda testified that her case was complicated because it involved multiple impairments that effect different physical systems, and that the net result would be days where her overall functioning would be effected to a greater or lesser degree.
Essentially, Davis's argument rests on the assertion that the ALJ misrepresented the true nature of the ME's testimony, and so such misrepresentation cannot be a good reason for discounting it. A review of that testimony in full establishes that Davis is correct in her contention.
First, I note that although the ALJ stated that the ME was called to "clarify the record," that is correct insofar as it goes but not wholly complete. A more complete statement would have included the fact that this matter was on remand from the Appeals Council, which had sent it back for a new hearing with a specific mandate, among others, that a medical expert be obtained to determine if Davis's impairments meets or equals the severity of a listing.
Listing 14.10 provides two alternative ways to meet the listing. First, under Part A, which essentially addresses the scope of the disease, the listing focuses on whether the disease affects two or more body systems or organs to at least a moderate degree with at least two of the recognized symptoms. Part B, which may be said to be concerned with severity of symptoms, does not require the involvement of multiple body systems, but deals with whether the claimant has two or more of the recognized symptoms and at least one of them is to a marked degree.
In that respect, the ALJ initially focused on Part A of the listing 14.10, which concerns the presence of the syndrome in multiple body systems.
The ALJ then moved to Part B, which focuses of frequency and severity of the symptoms by requiring repeated manifestations of at least two signs or symptoms of Sjorgen's Syndrome, with one of them being at a marked level of severity.
The ME responded by saying that Davis's limitations don't "necessarily rise up meet or equal [the] list for Sjorgen's Syndrome."
Picking up on that last exchange, Davis's counsel asked the ME whether Davis wouldn't be found to have a marked limitation in activities of daily living, in as much as the evidence showed that she has a home health aide, needs oxygen and uses a walker.
The ME responded, "Clearly there is, your honor."
The ME then testified that this limitation was "between moderate and marked."
Without immediately trying to clarify that statement, the ALJ then moved to the area of maintaining social functioning, asking the ME if he had an opinion "as far as her impairments affect that?"
The ME responded:
Finally, with respect to the level of her impairments in the area of concentration, persistence and pace, the ME opined:
Under follow-up questioning from claimant's counsel, the ME expanded on his testimony by stating that "typically," Davis would have only a moderate impairment in the areas of social interaction and daily functioning. But, he also said that "it may be marked on certain days. I can see it when her illnesses are worse on those days that clearly it would be marked, but on average I think it's probably more of a moderate level there."
The ALJ then had this exchange with the ME:
That exchange prompted this critical colloquy with the claimant's attorney:
At this point, the ALJ ended the discussion of Listing 14.10, and shifted the discussion to the listing on COPD.
On review of this testimony, it is plain as an initial matter that it was not a model of probity and clarity. But, that said it does not follow, as the ALJ maintains, that the ME was "hedging" about the level of severity of Davis's symptoms. Rather, it seems that the ME was consistently emphasizing that the level of severity would vary according to whether Davis was having a "good day" or a "bad day."
Further, for that same reason, it is not fully correct to say that the ME "guessed" that all of Davis's impairments were moderate, or that "Dr. Simmagadda could not state with any conviction" that her impairments were more than moderate. As the detailed exposition of the testimony shows, the ME was being careful in trying to describe a situation where symptoms associated with one disorder may be aggravated in severity by other impairments,
I also note that the ALJ himself chose to abort the examination of the ME at a critical juncture, when a few additional questions may have fully clarified the testimony. In particular, when the ME testified that Davis's limitation in the area of concentration, persistence and pace would be marked on bad days, while moderate on "lesser impact days," the obvious follow up question would have been to ask if the ME had an opinion as to how many days would fall into each category.
Further, and much more important, all parties exhibited a fundamental misunderstanding of the categories of "marked" or "moderate," inasmuch as these terms include in themselves an assessment of how the frequency of a symptom affects a claimant's ability to function. Section 14.00(I)(2), applicable to immune system disorders like Sjorgen's, states that the evaluation of symptoms in light of their functional impact includes both "the frequency and duration" of any symptoms, which includes consideration of "periods of exacerbation and remission." Thus, Section 14.00(I)(4) states that to satisfy the "marked" limitation criteria, the ultimate test is to determine the "nature and overall degree of interference with . . . functioning."
Thus, even if the "repeated manifestations" of symptoms, as Part B describes, includes days when the symptoms are severe and days when they are not, the overall result may constitute a "marked" impairment if collectively those symptoms "seriously interfere" with the ability to "function independently, appropriately and effectively."
It appears that all parties here were, at the very least, imprecise in assuming that "marked" or "moderate" referred solely to severity, while a separate, independent measure or term was needed to assess the effect of "good days and bad days" on function. In fact, as noted, the term "marked" encompasses both an evaluation of the frequency and severity of symptoms as understood in light of the overall effect on function. Much greater clarity would have resulted here if the participant's common understanding of the terms had been corrected, and Dr. Simmigadda had clearly given his opinion as to functional limits in accord with the standard already set out in the regulations.
But that clarification was never made, and the additional questions as to the frequency of good and bad days was never asked, as the ALJ at that point simply "moved on" to consider the listing for COPD.
In the end, I find that the ALJ's reasons for discounting Dr. Simmagadda's opinion are not good ones, as discussed above. Further, the question of whether Davis meets or equals Listing 14.10 — a key point of the remand from the Appeals Council — remains unanswered, despite testimony from the required ME than came tantalizingly close to resolving this matter, but broke down or remained incomplete as detailed above.
Therefore, for the reasons stated, it is necessary to once again send this matter back for further consideration, with the renewed direction to obtain the testimony of a medical expert on the question of whether Davis meets or equals Listing 14.10.
For the reasons stated, substantial evidence does not support the finding of the Commissioner that Davis had no disability. Therefore, the denial of Davis's application is reversed and the matter remanded for further proceedings consistent with this opinion.
IT IS SO ORDERED.